Deutsche Bank
PYXS icon

Deutsche Bank’s Pyxis Oncology PYXS Stock Holding History

Deutsche Bank’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,390
Closed -$27.8K – 3708
2025
Q1 		$27.8K Sell
28,390
-1,910
-6% -$2.55K ﹤0.01% 3452
2024
Q4 		$47.3K Sell
30,300
-208,090
-87% -$600K ﹤0.01% 3423
2024
Q3 		$875K Hold
238,390
– – ﹤0.01% 2178
2024
Q2 		$789K Buy
238,390
+73,390
+44% +$309K ﹤0.01% 2116
2024
Q1 		$703K Buy
165,000
+40,000
+32% +$168K ﹤0.01% 2188
2023
Q4 		$225K Hold
125,000
– – ﹤0.01% 2805
2023
Q3 		$249K Hold
125,000
– – ﹤0.01% 2634
2023
Q2 		$320K Buy
125,000
+100,000
+400% +$317K ﹤0.01% 2615
2023
Q1 		$100K Hold
25,000
– – ﹤0.01% 3327
2022
Q4 		$33.5K Hold
25,000
– – ﹤0.01% 3675
2022
Q3 		$49K Hold
25,000
– – ﹤0.01% 3604
2022
Q2 		$60K Sell
25,000
-5,783
-19% -$15.4K ﹤0.01% 3708
2022
Q1 		$124K Sell
30,783
-678
-2% -$4.96K ﹤0.01% 3498
2021
Q4 		$345K Buy
+31,461
New +$360K ﹤0.01% 3063

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's PYXS Position: Q2 2025 in Review

Deutsche Bank sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 28,390 shares — an estimated $27.8K sold.

Deutsche Bank first reported a position in PYXS in Q4 2021 and held it in 14 quarters. The position peaked at $875K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • Deutsche Bank reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 28,390 Pyxis Oncology shares in Q2 2025, an estimated $27.8K.
  • Deutsche Bank first reported a position in Pyxis Oncology in Q4 2021 and held it in 14 quarters.
  • Deutsche Bank's Pyxis Oncology position peaked at $875K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.